Krystal Parrish is a pharmacist who is specialized in Critical Care in Tampa, Florida. Patients can reach her at 813 W Bearss Ave, Tampa or contact her on 813-908-0360. Active license number of Krystal Parrish is PS52806 for Critical Care in Florida. Krystal Parrish is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Krystal Parrish speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Krystal Parrish
Specialization:
Critical Care
Credentials:
PHARMD
Gender:
Female
Location:
813 W Bearss Ave, Tampa, Florida, 33613-1233
Phone:
813-908-0360
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Krystal Parrish are as mentioned below.
NPI Number:
1528784220
NPI Enumeration Date:
13 Oct, 2022
NPI Last Update On:
13 Oct, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Krystal Parrish are as mentioned below.
Specialization
License Number
State
Status
Critical Care
PS52806
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
813 W Bearss Ave, Tampa, Florida
Zip:
33613-1233
Phone Number:
813-908-0360
Fax Number:
--
Patients can reach Krystal Parrish at 813 W Bearss Ave, Tampa, Florida or can call on phone at 813-908-0360.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.